Prof. Dr. Andreas Diefenbach
January 19, 9.15: Keynote
How the microbiota controls the setpoint of the innate immune system
About Prof. Dr. Andreas Diefenbach
Andreas Diefenbach is Professor and Chair of Microbiology and Immunology at the Charité – Universitätsmedizin Berlin and Senior Group Leader at the German Rheumatism Research Center. His lab studies transcriptional and epigenetic control of cell fate decisions in the innate immune system. Current research interests include how the immune system coordinates adaptation of multicellular organisms to constantly changing environments (microbiota, nutrients).
Andreas studied Medicine at the University of Erlangen and graduated in Microbiology and Immunology (1998). He obtained postdoctoral training at the Department of Molecular and Cellular Biology, University of California Berkeley (1999-2002). Prior to joining Charité, he was an Assistant Professor at the Skirball Institute of Biomolecular Medicine, New York University (2003-2006), a Full Professor at the University of Freiburg (2006-2013) and Professor and Chair of Medical Microbiology and the coordinator of the Research Centre of Immunology at the Johannes-Gutenberg-University of Mainz (2013-2016).
As a Physician Scientist, Andreas won grant support by the Howard Hughes Medical Institute, by the European Research Council, and by the Deutsche Forschungsgemeinschaft (DFG). He is the coordinator of the DFG Priority Program 1937 (“Innate Lymphoid Cells”). He was awarded with the Main Scientific Prize of the German Society of Hygiene and Microbiology. Since 2017, he is recognized as one of the Highly Cited Researchers (Clarivate Analytics) selected on the basis of “consistent production” of highly cited papers in the last 11 years (defined as those that rank in the top 1% by citations for field and publication year).